Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-03

FDA Approved: VALSARTAN — Supplemental Application (SQUARE PHARMACEUTICALS LIMITED)

View source ↗

Summary

FDA approved a supplemental application for valsartan submitted by Square Pharmaceuticals Limited. This approval pertains to the generic product under ANDA20534…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)